Skip to content

Impedance Measurements in Heart Failure Patients

Impedance Measurements in Heart Failure Patients

Status
Terminated
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01509495
Acronym
SIM-HF
Enrollment
20
Registered
2012-01-13
Start date
2011-12-31
Completion date
2014-05-31
Last updated
2014-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart Failure, HF

Brief summary

The purpose of this study is to measure impedance during inpatient treatment.

Interventions

DEVICEAkern BIA101 and Custom Device

Impedance Measurement every 4 hours

Sponsors

Medtronic BRC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients admitted to hospital for symptoms of congestive heart failure * patients older than 18 years * patients willing and able to give informed consent

Exclusion criteria

* patients who will require adrenergic or positive inotropic medications * patients enrolled in a concurrent study that may confound the results of this study * patients unable or unwilling to participate in study procedures * patients who are pregnant * patients who are mentally handicapped or legal incompetent * patients who are dependent on investigator or sponsor

Design outcomes

Primary

MeasureTime frame
Impedance Measurement of Patients in Heart Failure, impedance change first to last measurementevery 4 hours up to 48 hours

Secondary

MeasureTime frame
Accuracy of Respiratory rate determined by impedance measurementsevery 4 hours up to 48 hours
Correlation between hemodynamic (central venous or arterial pressure) and impedance measurements (optional)every 4 hours up to 48 hours

Countries

Czechia, Germany, Slovakia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026